Zachary Kaufman

Vice President of Product Management at xCures

Zachary Kaufman has extensive work experience in product and program management roles. Zachary is currently the Vice President of Product Management at xCures, where they have been working since 2019. Prior to this role, Zachary served as the Director of Product Management at xCures from 2021 to 2023, and as the Director of Program Management from 2019 to 2021.

Before joining xCures, Zachary worked as a Program Manager at Myriad Women's Health (formerly Counsyl) from 2017 to 2019. Zachary also worked as a Product Manager at ERT Imaging (formerly ImageIQ, now Clario) from 2014 to 2017.

In addition to these roles, Zachary gained additional experience through various positions from 2013 to 2017. Zachary was also a Fellow at Venture For America from 2014 to 2016.

Zachary Kaufman attended Washington University in St. Louis from 2010 to 2014, where they obtained a Bachelor of Science (B.S.) degree. Their major was in Biomedical Engineering & Archaeology. In addition, they obtained a certification as a Certified Project Manager (CPM) from the Project Management Leadership Group, Inc. (PMLG) in March 2018.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


xCures

The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, withan AI-based precision oncology platform that tightly integrates cancer research and care.The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives.


Industries

Employees

11-50

Links